\begin{thebibliography}{10}

\bibitem{Zhou2018}
Heng Zhou, Thomas~A. Murray, Haitao Pan, and Ying Yuan.
\newblock {Comparative review of novel model-assisted designs for phase I
  clinical trials}.
\newblock {\em Statistics in Medicine}, 37(14):2208--2222, 2018.

\bibitem{Love2017}
Sharon~B. Love, Sarah Brown, Christopher~J. Weir, Chris Harbron, Christina Yap,
  Birgit Gaschler-Markefski, James Matcham, Louise Caffrey, Christopher
  McKevitt, Sally Clive, Charlie Craddock, James Spicer, and Victoria
  Cornelius.
\newblock {Embracing model-based designs for dose-finding trials}.
\newblock {\em British Journal of Cancer}, 117(3):332--339, 2017.

\bibitem{Ananthakrishnan2017}
Revathi Ananthakrishnan, Stephanie Green, Mark Chang, Gheorghe Doros, Joseph
  Massaro, and Michael LaValley.
\newblock {Systematic comparison of the statistical operating characteristics
  of various Phase I oncology designs}.
\newblock {\em Contemporary Clinical Trials Communications}, 5:34--48, 2017.

\bibitem{Rogatko2007}
Andr{\'{e}} Rogatko, David Schoeneck, William Jonas, Mourad Tighiouart,
  Fadlo~R. Khuri, and Alan Porter.
\newblock {Translation of innovative designs into phase I trials}.
\newblock {\em Journal of Clinical Oncology}, 25(31):4982--4986, 2007.

\bibitem{Chiuzan2017}
Cody Chiuzan, Jonathan Shtaynberger, Gulam~A. Manji, Jimmy~K. Duong, Gary~K.
  Schwartz, Anastasia Ivanova, and Shing~M. Lee.
\newblock {Dose-finding designs for trials of molecularly targeted agents and
  immunotherapies}.
\newblock {\em Journal of Biopharmaceutical Statistics}, 27(3):477--494, 2017.

\bibitem{Wheeler2019}
Graham~M. Wheeler, Adrian~P. Mander, Alun Bedding, Kristian Brock, Victoria
  Cornelius, Andrew~P. Grieve, Thomas Jaki, Sharon~B. Love, Lang'O Odondi,
  Christopher~J. Weir, Christina Yap, and Simon~J. Bond.
\newblock {How to design a dose-finding study using the continual reassessment
  method}.
\newblock {\em BMC Medical Research Methodology}, 19(1):1--15, 2019.

\bibitem{Cheung2000}
Ying~Kuen Cheung and Rick Chappell.
\newblock {Sequential Designs for Phase I Clinical Trials with Late-Onset
  Toxicities}.
\newblock {\em Biometrics}, 56(4):1177--1182, 2000.

\bibitem{Polley2019}
Mei-Yin~C. Polley and Ying~Kuen Cheung.
\newblock {Early-Phase Platform Trials: A New Paradigm for Dose Finding and
  Treatment Screening in the Era of Precision Oncology}.
\newblock {\em JCO Precision Oncology}, (3):1--8, 2019.

\bibitem{Braun2002}
Thomas~M. Braun.
\newblock {The bivariate continual reassessment method: Extending the CRM to
  phase I trials of two competing outcomes}.
\newblock {\em Controlled Clinical Trials}, 2002.

\bibitem{Thall2004}
Peter~F Thall and John~D Cook.
\newblock {Dose-Finding Based on Efficacy â€“ Toxicity Trade-Offs}.
\newblock {\em Biometrics}, (September):684--693, 2004.

\bibitem{Wages2013}
Nolan~A. Wages, Mark~R. Conaway, and John O'Quigley.
\newblock {Using the time-to-event continual reassessment method in the
  presence of partial orders}.
\newblock {\em Statistics in Medicine}, 32(1):131--141, 2013.

\bibitem{OQuigley2003}
John O'Quigley and Xavier Paoletti.
\newblock {Continual reassessment method for ordered groups}.
\newblock {\em Biometrics}, 59(2):430--440, 2003.

\bibitem{OQuigley1999}
J.~O'Quigley, L.~Z. Shen, and A.~Gamst.
\newblock {Two-sample continual reassessment method}.
\newblock {\em Journal of Biopharmaceutical Statistics}, 9(1):17--44, 1999.

\bibitem{Conaway2018}
Mark~R Conaway.
\newblock {A design for phase I trials in completely or partially ordered
  groups}.
\newblock 36(15):2323--2332, 2018.

\bibitem{Horton2019}
Bethany~Jablonski Horton, Nolan~A. Wages, and Mark~R. Conaway.
\newblock {Shift models for dose-finding in partially ordered groups}.
\newblock {\em Clinical Trials}, 16(1):32--40, 2019.

\bibitem{Cunanan2018}
Kristen~M. Cunanan and Joseph~S. Koopmeiners.
\newblock {Hierarchical models for sharing information across populations in
  phase I dose-escalation studies}.
\newblock {\em Statistical Methods in Medical Research}, 27(11):3447--3459,
  2018.

\bibitem{Cunanan2018a}
Kristen~M. Cunanan and Joseph~S. Koopmeiners.
\newblock {Efficacy/toxicity dose-finding using hierarchical modeling for
  multiple populations}.
\newblock {\em Contemporary Clinical Trials}, 71(June):162--172, 2018.

\bibitem{Wages2015a}
Nolan~A. Wages and Christopher Tait.
\newblock {Seamless Phase I/II Adaptive Design for Oncology Trials of
  Molecularly Targeted Agents}.
\newblock {\em Journal of Biopharmaceutical Statistics}, 25(5):903--920, 2015.

\end{thebibliography}
